Alkem Labs Q2 Net up 14 percent at Rs 327.44 crore
New Delhi: Drug firm Alkem Laboratories reported a 13.63 percent rise in consolidated net profit at Rs 327.44 crore for the quarter ended September 30 on account of robust sales.
The company had posted a net profit of Rs 288.15 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a filing to BSE.
Consolidated total income of the company stood at Rs 1,888.95 crore for the quarter under consideration as against Rs 1,672.27 crore for the same period year ago.
"Q2 FY18 has been a robust quarter for the company helped by post-GST channel filing in the India business and a healthy double-digit growth in international business," Alkem Laboratories MD Sandeep Singh said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd